Clinical Trends for May 2016

Ryan Syrek


May 27, 2016

Clinical Trend of the Week (May 7-13): Hypertonic Saline

Recent analysis of two meta-analyses has found that the administration of nebulized hypertonic saline (HS) does not reduce length of stay for infants with bronchiolitis. Confusion has surrounded the practice for years, but physicians now clearly have an answer: HS will not result in a decrease in length of stay for kids with bronchiolitis. Alan Schroeder, MD, associate chief for research in the Division of Hospital Medicine and associate clinical professor at Lucille Packard Children's Hospital Stanford in California, who was not involved with the study, told Medscape Medical News that although he does not personally order HS, clinicians who do should now reconsider that practice. Hopefully this study prompted more searches by physicians looking to reassess their current plans.

For more information on Bronchiolitis, read here.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.